Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 9, 2013, Pages 749-755

  Bai, Kehua ^a   Wang, Ke ^a   Li, Xiaoyu ^b   Wang, Jie ^c   Zhang, Jie ^d   Song, Li ^a   Wang, Jin ^c   Zhang, Suli ^a   Lau, Wayne Bond ^e   Ma, Xinliang ^a,e   Liu, Huirong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANXI TUMOR HOSPITAL   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SYDNEY   (Australia)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Angiotensin II type 1 receptor; Autoantibody; Calcium; Platelet aggregation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; CALCIUM; COLLAGEN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; PREECLAMPSIA; PREGNANCY; THROMBOCYTE; THROMBOCYTE AGGREGATION; YOUNG ADULT;

ANGIOTENSIN II TYPE 1 RECEPTOR; AUTOANTIBODY; CALCIUM; PLATELET AGGREGATION;

ADULT; AUTOANTIBODIES; BLOOD PLATELETS; CALCIUM; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; PLATELET AGGREGATION; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; YOUNG ADULT;

EID: 84883230285     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt059     Document Type: Article

References (24)

1. Ananth CV and Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality in first and higher order births: a populationbased study. Epidemiology 2010, 21: 118-123.
2. Hernandez-Diaz S, Toh S and Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 2009, 18: b2255.
3. Walker RL, Hemmelgarn B and Quan H. Incidence of gestational hypertension in the Calgary Health Region from 1995 to 2004. Can J Cardiol 2009, 25: e284-e287.
4. Norris LA, Gleeson N, Sheppard BL and Bonnar J. Whole blood platelet aggregation in moderate and severe pre-eclampsia. Br J Obstet Gynaecol 1993, 100: 684-688.
5. Felfernig-Boehm D, Salat A, Vogl SE, Murabito M, Felfernig M, Schmidt D and Mittlboeck M, et al. Early detection of preeclampsia by determination of platelet aggregability. Thromb Res 2000, 98: 139-146.
6. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F and Hering L, et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007, 49: 604-611.
7. Kappelle LJ. Inhibition of platelet aggregation and angiotensin II-receptor blockade following TIA; the unexpected results of the Prevention Regimen For Effectively Avoiding Second Strokes (PROFESS) trial. Ned Tijdschr Geneeskd 2008, 152: 1907-1910.
8. Utsugisawa K, Kizawa H, Nagane Y, Kondoh R, Iwa Y, Akutsu H and Tohgi H, et al. Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets. Thromb Haemost 2005, 94: 1012-1018.
9. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A and Baur E, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103: 945-952.
10. Thway TM, Shlykov SG, Day MC, Sanborn BM, Gilstrap LC, 3rd, Xia Y and Kellems RE. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 2004, 110: 1612-1619.
11. Bautista MJ, Ruiz-Villamor E, Salguero FJ, Sánchez-Cordón PJ, Carrasco L and Gómez-Villamandos JC. Early platelet aggregation as a cause of thrombocytopenia in classical swine fever. Vet Pathol 2002, 39: 84-91.
12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A and Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001, 20: IX-XIV.
13. Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X and Cheng X, et al. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens 2008, 26: 1629-1635.
14. Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD and Equchi S. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 2006, 4: 67-78.
15. Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT and Cheng LX. Autoantibodies against AT1-receptor and a1-adrenergic receptor in patients with hypertension. Hypertens Res 2002, 25: 641-646.
16. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R and Kintscher U, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005, 352: 558-569.
17. Zhang SL, Du YH, Wang J, Yang LH, Yang XL, Zheng RH and Wu Y, et al. Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats. Acta Pharmacol Sin 2010, 31: 1381-1388.
18. Farndale RW, Sixma JJ, Barnes MJ and De Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004, 2: 561-573.
19. Haller H, Oeney T, Hauck U, Distler A and Philipp T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertens 1989, 2: 238-243.
20. Hojo M, Suthanthiran M, Helseth G and August P. Lymphocyte intracellular free calcium concentration is increased in preeclampsia. Am J Obstet Gynecol 1999, 180: 1209-1214.
21. Juška A. Calcium fluxes into and out of cytosol in human platelets: analysis of experimental data. Biochem Biophys Res Commun 2011, 412: 537-542.
22. He X, Bi XY, Wang H, Yu XJ and Zang WJ. Progress in calcium regulation in myocardial and vascular ischemia-reperfusion injury. Shengli Xuebao 2012, 64: 321-326.
23. Harper MT and Poole AW. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets. J Thromb Haemost 2011, 9: 1599-1607.
24. Jin YR, Ryu CK, Moon CK, Cho MR and Yun YP. Inhibitory effects of J78, a newly synthesized 1, 4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation. Pharmacology 2004, 70: 195-200.